European Pharmaceutical Review

MARCH 14, 2023

This is due to the regulatory requirements imposed on parallel imported medicinal products in various Member States, the fulfilment of which often requires repackaging. Repackaging a medicinal product… means that the trademark is reapplied by an entity other than the trademark proprietor.”

Packaging 98

Packaging Generic Medicine Labelling Pharmaceutical Companies 98

STAT

OCTOBER 10, 2023

But the   drumbeat of layoffs in 2022   has only grown louder this year. biopharma firms cut about 6,000 jobs in 2022 and 11,000 so far this year. percent to about 114,000 in 2022, compared to nearly 107,000 the year before, according to a  report released Sept. He estimated U.S. Absolutely.” ”

Vaccines 136

Vaccines Generic Medicine Packaging 136

pharmaphorum

JANUARY 30, 2023

These include allowing the exceptional supply of certain medicines that may not be authorised in a particular Member State or granting full or partial exemptions to certain labelling and packaging requirements to address severe problems in respect of the availability of some medicines.”

Generic Medicine 104

Generic Medicine Packaging FDA Labelling 104

European Pharmaceutical Review

FEBRUARY 2, 2023

The recent update to the EC Urban Waste Directive, part of the environment package ‘Towards Zero Pollution,’ 4 has a disproportionate producer responsibility principle that will incur considerable extra costs. This is likely to make some essential medicines and APIs economically unsustainable to manufacture.

Generic Medicine 111

Generic Medicine Packaging Documentation Pharmaceutical Companies 111